All Stories

  1. Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?

    Article • Current Medicinal Chemistry, December 2024, Bentham Science Publishers

    Vasily N Sukhorukov

  2. Use of Olives-derived Phytochemicals for Prevention and Treatment of Atherosclerosis: An Update

    Article • Current Topics in Medicinal Chemistry, October 2024, Bentham Science Publishers

    Siarhei Dabravolski, Vasily N Sukhorukov

  3. Cholesteryl Ester Transfer Protein Variations and Cardiovascular Diseases

    Article • Current Pharmaceutical Design, March 2024, Bentham Science Publishers

    Vasily N Sukhorukov, Siarhei Dabravolski

  4. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Prof Marcello Ciaccio, anca mihaela PANTEA STOIAN, Vasily N Sukhorukov, Alexander Orekhov

  5. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis, and Treatment of Global Diseases

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Vasily N Sukhorukov

  6. Atherosclerosis prevention the role of special diets and functional food

    Article • Frontiers in Bioscience-Elite, January 2020, Frontiers in Bioscience

    Vasily N Sukhorukov

  7. Prevention of atherosclerosis the role of special diets and functional foods

    Article • January 2020, Frontiers in Bioscience

    Vasily N Sukhorukov

  8. Heteroplasmic Variants of Mitochondrial DNA in Atherosclerotic Lesions of Human Aortic Intima

    Article • Biomolecules, September 2019, MDPI AG

    Vasily N Sukhorukov

  9. Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part II

    Article • Current Pharmaceutical Design, June 2019, Bentham Science Publishers

    Vasily N Sukhorukov

  10. Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part I

    Article • Current Pharmaceutical Design, May 2019, Bentham Science Publishers

    Vasily N Sukhorukov

  11. Transcriptional Characteristics of Activated Macrophages

    Article • Current Pharmaceutical Design, May 2019, Bentham Science Publishers

    Vasily N Sukhorukov

  12. Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, May 2019, Elsevier

    Vasily N Sukhorukov

  13. Translation of Basic Research into Clinical Practice: Focus on Cell-Based Diagnostics and Therapy

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Vasily N Sukhorukov, Alexander Orekhov

  14. Diagnostics and Therapy of Human Diseases - Focus on Sialidases

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Vasily N Sukhorukov, Alexander Orekhov

  15. Current Approaches to Diagnostics and Therapies of Chronic Diseases: Focus on Molecular and Cell Biology

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Alexander Orekhov, Vasily N Sukhorukov

  16. HDL activates expression of genes stimulating cholesterol efflux in human monocyte-derived macrophages

    Article • Experimental and Molecular Pathology, October 2018, Elsevier

    Vasily N Sukhorukov

  17. Sialidases: Therapeutic and Antiatherogenic Potential

    Article • Current Pharmaceutical Design, December 2017, Bentham Science Publishers

    Mr Emile R Zakiev, Vasily N Sukhorukov, Alexander Orekhov

  18. HDL-Targeting Therapeutics: Past, Present and Future

    Article • Current Pharmaceutical Design, April 2017, Bentham Science Publishers

    Vasily N Sukhorukov, Anatol Kontush

  19. Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients'; Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity

    Article • Current Pharmaceutical Design, March 2017, Bentham Science Publishers

    Vasily N Sukhorukov

  20. Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, February 2017, Elsevier

    Vasily N Sukhorukov

  21. Analysis of Apolipoprotein B Protein of Circulating Multiple-Modified Low-Density Lipoprotein

    Article • International Journal of Angiology, December 2016, Thieme Publishing Group

    Vasily N Sukhorukov

  22. Carbohydrate composition of circulating multiple-modified low-density lipoprotein

    Article • Vascular Health and Risk Management, October 2016, Dove Medical Press

    Vasily N Sukhorukov, Mr Emile R Zakiev, Alexander Orekhov

  23. Lipid composition of circulating multiple-modified low density lipoprotein

    Article • Lipids in Health and Disease, August 2016, Springer Science + Business Media

    Vasily N Sukhorukov

  24. Epigenetic factors in atherogenesis: MicroRNA

    Article • Biochemistry (Moscow) Supplement Series B Biomedical Chemistry, July 2016, Pleiades Publishing Ltd

    Vasily N Sukhorukov

  25. Epigenetic factors in atherogenesis: microRNA

    Article • Biomeditsinskaya Khimiya, January 2016, Institute of Biochemistry

    Vasily N Sukhorukov

  26. Atherogenic modification of low-density lipoproteins

    Article • Biomeditsinskaya Khimiya, January 2016, Institute of Biochemistry

    Vasily N Sukhorukov

  27. Neuron density in the hippocampus in rat strains with contrasting nervous system excitability after prolonged emotional-pain stress

    Article • Neuroscience and Behavioral Physiology, May 2008, Springer Science + Business Media

    Vasily N Sukhorukov